Alejandro Burga, group leader at IMBA, and David Haselbach, Technology Platform Head for cryo electron microscopy at the IMP, were selected by the…
Paralogous proteins have evolved from gene or whole genome duplications and may provide an insurance policy for deleterious mutations. Why some…
Heart disease kills 18 million people each year, but the development of new therapies faces a bottleneck: no physiological model of the entire human…
The European Research Council (ERC) awarded Consolidator Grants to three Vienna BioCenter group leaders, representing CeMESS, Max Perutz Labs and IMP.…
Stem cells can differentiate to replace dead and damaged cells. But how do stem cells decide which type of cell to become in a given situation? Using…
The Vienna BioCenter (VBC) is delighted to announce that nine of its distinguished researchers have been named on the 2023 Clarivate list of the…
The Max Perutz PhD Fellowship honors the most ambitious and innovative PhD projects at the institute. This year’s awardees are Jeanne Fesselet…
Approximately one in eight men will be diagnosed with prostate cancer in his lifetime. Prostate cancer is commonly androgen addicted, in which case…
Within the Vienna BioCenter, PhD students foster a strong sense of community. Annually, they organize the Vienna BioCenter PhD Symposium, a global…
Valneva announced that the U.S. Food and Drug Administration (FDA) has approved IXCHIQ®, Valneva’s single-dose, live-attenuated vaccine indicated for…
Swiss independent AVINA Stiftung has awarded one of its sought-after grants to Shaul Pollak, a group leader at the Division for Microbial Ecology at…
The Proteomics Technology Hub, shared between the IMP, IMBA, and GMI, aims to keep the Vienna BioCenter at the forefront of proteomics technology.…
The website uses cookies to ensure you get the best experience on our website.
Anonymous evaluation for troubleshooting and further development
Purpose: error analysis, statistical evaluation of our website accesses, campaign analysis, conversion tracking, retargeting Processing operations: Collection of access data, data from your browser and data about the content accessed; Execution of analysis software and storage of data on your terminal device, anonymization of the data collected; Evaluation of the anonymous data in the form of statistics Storage period: data on your device for up to two years. Joint controller: Google Ireland Limited, Gordon House, Barrow Street, Dublin 4, Ireland Legal basis for data processing: voluntary, consent that can be revoked at any time Consequences of non-consent: No direct impact on the functionality of the website; however limited opportunities for further development and error analysis Data transfer to the USA: Your data is processed by the provider Google in the USA, which involves corresponding risks, e.g. B. a secret data access by US authorities. With your consent, you also consent to the processing of your data in the USA.